Education
About Us
Working with TipRanks
Follow Us
Viva Biotech Holdings (HK:1873)
:1873
1873 Stock Chart & Stats
HK$1.99
-HK$0.01(-1.20%)
At close: 4:00 PM EST
HK$1.99
-HK$0.01(-1.20%)
Day’s Range― - ―
52-Week RangeHK$0.77 - HK$3.27
Previous CloseN/A
Volume129.00K
Average Volume (3M)10.31M
Market Cap
HK$4.88B
Enterprise ValueHK$4.12B
Total Cash (Recent Filing)HK$904.45M
Total Debt (Recent Filing)HK$1.16B
Price to Earnings (P/E)26.5
Beta2.36
Next Earnings
Mar 26, 2026EPS EstimateN/A
Last Dividend Ex-Date
Jun 16, 2021Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding2,128,434,300
10 Day Avg. Volume10,852,121
30 Day Avg. Volume10,305,290
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)0.45
Price to Sales (P/S)0.87
P/FCF Ratio9.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Viva Biotech Holdings News
1873 FAQ
What was Viva Biotech Holdings’s price range in the past 12 months?
Viva Biotech Holdings lowest stock price was HK$0.77 and its highest was HK$3.27 in the past 12 months.
What is Viva Biotech Holdings’s market cap?
Viva Biotech Holdings’s market cap is HK$4.88B.
When is Viva Biotech Holdings’s upcoming earnings report date?
Viva Biotech Holdings’s upcoming earnings report date is Mar 26, 2026 which is in 137 days.
How were Viva Biotech Holdings’s earnings last quarter?
Viva Biotech Holdings released its earnings results on Aug 28, 2025. The company reported HK$0.055 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.055.
Is Viva Biotech Holdings overvalued?
According to Wall Street analysts Viva Biotech Holdings’s price is currently Overvalued.
Does Viva Biotech Holdings pay dividends?
Viva Biotech Holdings pays a Notavailable dividend of HK$0.01 which represents an annual dividend yield of N/A. See more information on Viva Biotech Holdings dividends here
What is Viva Biotech Holdings’s EPS estimate?
Viva Biotech Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Viva Biotech Holdings have?
Viva Biotech Holdings has 2,128,434,300 shares outstanding.
What happened to Viva Biotech Holdings’s price movement after its last earnings report?
Viva Biotech Holdings reported an EPS of HK$0.055 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.51%.
Which hedge fund is a major shareholder of Viva Biotech Holdings?
Currently, no hedge funds are holding shares in HK:1873
Viva Biotech Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
177.01%
12-Months-Change
Fundamentals
Return on Equity
4.45%
Trailing 12-Months
Asset Growth
-2.26%
Trailing 12-Months
Company Description
Viva Biotech Holdings
Viva Biotech Holdings (1873) is a biotechnology company based in China that specializes in drug discovery and development services. The company operates primarily in the pharmaceutical sector, offering a range of services including drug design, screening, and optimization, as well as providing innovative solutions to biopharmaceutical companies to streamline their research processes. With a focus on precision medicine and a commitment to enhancing drug development efficiency, Viva Biotech has positioned itself as a partner of choice for both domestic and international clients in the life sciences industry.
Technical Analysis
Shanghai Junshi Biosciences Co., Ltd. Class H
―
Simcere Pharmaceutical Group Limited
―
Lepu Biopharma Co. Ltd. Class H
―
Shanghai Henlius Biotech, Inc. Class H
―
Shandong Boan Biotechnology Company., Limited. Class H
―
Options Prices
Currently, No data available
---